Loading...

News List

浙江大学医学院研究者们揭示了靶向DDK的概念可以提高肝癌的免疫治疗效果

2023-08-29


肝细胞癌是一种常见的高度侵袭性肿瘤,已被公认为全球第七大常见恶性肿瘤和第四大癌症相关死亡原因。尽管近几十年来,肝细胞癌的临床治疗取得了长足的进步,包括根治性切除、介入治疗、肝移植到靶向治疗或免疫治疗,但由于其隐匿性和侵袭性,估计的5年生存率仍低至14-18%。因此,人们正在努力进一步提高我们对肝癌分子发病机制的认识,以期开发新的治疗策略,降低这种恶性肿瘤的死亡率。

Pre: On July 14, Bojian's listing application for tofersen injection was accepted.

Next: Researchers at Zhejiang University School of Medicine have revealed that the concept of targeting DDK can improve the efficacy of immunotherapy for liver cancer

We would like to use cookies to better understand your use of this website, which will help improve your experience on future visits to the website. You can change this setting in your browser settings. For more information about the use of cookies, please refer to our Privacy Policy.